ECT(SZ:300679)2024-04-22 12:56Financial Performance - The company's revenue for Q1 2024 reached ¥1,040,259,781.57, representing a 68.77% increase compared to ¥616,360,334.85 in the same period last year[6]. - Net profit attributable to shareholders was ¥161,791,268.06, a significant increase of 244.43% from ¥46,973,395.58 year-on-year[6]. - The net profit after deducting non-recurring gains and losses was ¥150,697,518.73, up 252.06% from ¥42,804,528.11 in the previous year[6]. - Basic earnings per share rose to ¥0.3830, reflecting a 243.50% increase compared to ¥0.1115 in the same period last year[6]. - The total operating revenue for the first quarter of 2024 reached ¥1,040,259,781.57, a significant increase from ¥616,360,334.85 in the same period last year, representing a growth of approximately 68.8%[31]. - The total operating costs for the first quarter of 2024 were ¥885,844,157.47, compared to ¥582,378,245.52 in the previous year, indicating an increase of about 52.2%[31]. - The net profit for Q1 2024 was CNY 165,866,793.08, a significant increase from CNY 44,766,813.46 in Q1 2023, representing a growth of approximately 270%[35]. - Operating profit for Q1 2024 was CNY 186,784,959.87, up from CNY 53,773,693.49 in Q1 2023, indicating a growth of approximately 247%[35]. - The total comprehensive income attributable to the parent company for Q1 2024 was CNY 161,638,198.02, compared to CNY 46,485,310.27 in Q1 2023, showing an increase of about 248%[36]. Assets and Liabilities - The company's total assets increased by 3.19% to ¥6,494,901,371.44 from ¥6,294,397,634.94 at the end of the previous year[6]. - The total assets as of March 31, 2024, were ¥6,494,901,371.44, compared to ¥6,294,397,634.94 at the beginning of the year, showing a growth of approximately 3.2%[30]. - The total liabilities at the end of Q1 2024 were ¥1,639,228,340.91, slightly up from ¥1,616,161,652.63 at the start of the year, indicating an increase of about 1.4%[31]. - The company's non-current assets totaled ¥2,874,672,294.91 as of March 31, 2024, compared to ¥2,773,163,935.25 at the beginning of the year, reflecting an increase of approximately 3.7%[30]. - The retained earnings increased to ¥2,121,450,276.56 in Q1 2024 from ¥1,959,659,008.50 in Q1 2023, representing a growth of about 8.2%[31]. - The company reported a decrease in other payables to ¥34,307,985.92 from ¥68,114,467.37 year-over-year, indicating a reduction of approximately 49.6%[31]. Cash Flow - Cash flow from operating activities showed a slight decrease of 0.75%, totaling ¥64,264,502.59 compared to ¥64,749,454.34 in the previous year[6]. - Cash and cash equivalents at the end of Q1 2024 amounted to ¥1,050,577,173.65, down from ¥1,389,442,405.68 at the beginning of the period, reflecting a decrease of approximately 24.4%[26]. - The company experienced a net cash inflow from operating activities of CNY 861,227,590.58 in Q1 2024, compared to CNY 741,484,687.56 in Q1 2023, reflecting an increase of about 16%[38]. - Net cash outflow from operating activities totaled ¥796,963,087.99, an increase from ¥676,735,233.22 in the previous period[43]. - Net cash flow from investing activities was -¥324,446,790.46, a significant decrease compared to a positive ¥17,044,633.90 in the prior period[43]. - Cash flow from financing activities resulted in a net outflow of -¥80,674,084.97, worsening from -¥26,819,401.25 previously[43]. - The net increase in cash and cash equivalents was -¥338,865,232.03, contrasting with a positive increase of ¥53,980,737.89 in the last period[43]. - The ending balance of cash and cash equivalents stood at ¥950,566,483.90, down from ¥1,415,274,169.69 at the end of the previous period[43]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 13,023, with the top 10 shareholders holding an average of 53.15%[20]. - The largest shareholder, Chen Yuxuan, holds 20.40% of shares, totaling 86,145,461 shares[20]. - The second-largest shareholder, Lin Deying, holds 10.18% of shares, totaling 42,995,465 shares[20]. - The company had a total of 64,609,096 restricted shares at the end of the period, with 46,250 shares released from restriction[23]. - There are no significant changes in the top 10 shareholders' financing and securities lending activities compared to the previous period[20]. Research and Development - Research and development expenses for the quarter were ¥112,685,146.20, a 69.14% increase from ¥66,621,031.55 in the previous year, indicating a focus on innovation[16]. - Research and development expenses rose to CNY 112,685,146.20 in Q1 2024, compared to CNY 66,621,031.55 in the same period last year, marking an increase of about 69%[35]. - The company has not disclosed any new product launches or technological developments during this reporting period[24]. - The company has plans for market expansion and new product development, although specific details were not disclosed in the report[30]. Financing Activities - Cash paid for dividends, profits, or interest totaled $624,651.25, mainly for interest payments during the period[19]. - Cash paid for other financing activities increased by 255.33% to $95,297,067.64, attributed to employee stock plan payments and increased stock buybacks[19]. - The company plans to continue its stock buyback program as part of its capital allocation strategy[19]. - Cash paid to employees increased to ¥280,925,153.73 from ¥201,043,749.46[43]. - Cash paid for other operating activities rose to ¥96,796,784.17 from ¥68,537,006.39[43]. - Total cash inflow from financing activities was ¥65,735,133.92, with cash outflow totaling ¥146,409,218.89[43].